The share of Vigmed Holding AB will be listed on First North Premier as of 28 April 2015.

In line with previously announced plans for a change of listing to Small Cap, Vigmed is now, as a first step, changing trading venue to First North Premier. 

"The move to the Premier segment should be viewed as a signal to investors that the company's ambition is to have a high degree of transparency and that we are now gradually preparing the organisation for the requirements of the regulated market," says Vigmed’s Chairman, Lennart Holm.

Vigmed reports according to the IFRS principles as per the Annual Report of 2014.

First day of trading on First North Premier is April 28 2015.

For further information contact:

Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Finn Ketler +46 42 600 5311

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website:


Documents & Links